JCO Clinical Cancer Informatics
ISSN 2473-4276 · Lippincott Williams & Wilkins · United States · active 2017–2026
Metrics
- Best Scimago quartile (2025)
- Q1
- Cites per paper (2y)
- 2.7
- SJR
- 1.174
- h-index
- 56
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric (how the two differ). Citation rates differ enormously between fields, so compare within a discipline. What the other figures mean: journal quartile, SJR, h-index and article processing charge.
Data as of 1 November 2026 (venue index build).
Scimago Journal Rank 2025
In the Scimago Journal Rank 2025 edition, JCO Clinical Cancer Informatics is Q1 in 1 of its 3 subject categories and Q2 in the other 2. Its best category quartile is Q1.
| Subject category | Quartile | Rank in category |
|---|---|---|
| Health Informatics | Q1 | #36 of 152 |
| Cancer Research | Q2 | #94 of 235 |
| Oncology | Q2 | #114 of 426 |
- Cites per document (2 years, Scopus)
- 3.06
- Documents indexed in 2025 (Scopus)
- 176
The quartile is the one Scimago prints for each category. Rank is the journal's position by SJR among the journals Scimago lists in that category (#1 is the highest); “—” means we hold no rank consistent with that quartile. The document count is what Scopus indexed that year, which can be lower than a journal's full output. Source: SCImago Journal Rank 2025 edition, from Scopus data (scimagojr.com, CC BY-NC).
JCO Clinical Cancer Informatics is Q1 in 1 of its 3 Scimago subject categories (2025 edition; best category Health Informatics: Q1, #36 of 152), with SJR 1.174 (Scimago) and an h-index of 56 (OpenAlex). Listed in Scopus, Web of Science, PubMed.
Is this the right journal for your paper?
The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.
Indexing & access
- Indexed in
- ScopusWeb of SciencePubMed
- Access status:
- hybrid. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is JCO Clinical Cancer Informatics a predatory journal?
Our screening does not flag JCO Clinical Cancer Informatics. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is JCO Clinical Cancer Informatics indexed in Scopus or Web of Science?
Per our venue index, JCO Clinical Cancer Informatics appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is the impact factor of JCO Clinical Cancer Informatics?
Papers in JCO Clinical Cancer Informatics are cited about 2.7 times each within two years of publication, and Scimago places it in Q1, with an h-index of 56. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.
What Scimago quartile is JCO Clinical Cancer Informatics (Q1, Q2, Q3, or Q4)?
In the Scimago Journal Rank 2025 edition, JCO Clinical Cancer Informatics is Q1 in 1 of its 3 subject categories and Q2 in the other 2. By category: Health Informatics: Q1, #36 of 152; Cancer Research: Q2, #94 of 235; Oncology: Q2, #114 of 426. Its best category quartile is Q1. Quartiles split the journals in a subject category into four equal groups by SJR, so Q1 is the most-cited quarter and Q4 the least; JCO Clinical Cancer Informatics is cited about 2.7 times per paper over two years, with an h-index of 56.
What is the Web of Science (JCR) quartile of JCO Clinical Cancer Informatics?
The Web of Science quartile comes from Clarivate's Journal Citation Reports (JCR), a proprietary product we neither license nor compute — so we cannot state a JCR quartile for JCO Clinical Cancer Informatics. The open equivalent is its best Scimago quartile, Q1 in Health Informatics, derived from Scopus citation data. Because JCR ranks against Web of Science and Scimago against Scopus, the two can differ, so check Clarivate's site directly if you need the JCR quartile specifically.
Is JCO Clinical Cancer Informatics open access?
Our index records its access status as "hybrid". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.
Ready to submit? Tools for your next paper
Similar venues
- Current Opinion in OncologyQ2 · Lippincott Williams & Wilkins
- Psycho-OncologyQ1 · Wiley
- European Journal of Cancer PreventionQ2 · Lippincott Williams & Wilkins
- Molecular and Clinical OncologyQ3 · Spandidos Publishing
- Melanoma ResearchQ2 · Lippincott Williams & Wilkins
- Lymphatic Research and BiologyQ2 · Mary Ann Liebert, Inc.
Compare it with its peers: Ranked Oncology journals — ranked by Scimago quartile and cites per paper, predatory venues excluded.